Skip to content

Aurinia Pharmaceuticals AUPH Property, plant and equipment at cost

Property, plant and equipment at cost at other companies

AbbVie logo
AbbVieABBV
Incyte logo
IncyteINCY
Abbott logo
AbbottABT

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.39B+78.5%

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's property, plant and equipment at cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's property, plant and equipment at cost?
Aurinia Pharmaceuticals (AUPH) reported property, plant and equipment at cost of $5.26M in Q1 2026.
How has Aurinia Pharmaceuticals's property, plant and equipment at cost changed year-over-year?
Aurinia Pharmaceuticals's property, plant and equipment at cost decreased by 0.0% year-over-year, from $5.26M to $5.26M.
What is the long-term trend for Aurinia Pharmaceuticals's property, plant and equipment at cost?
Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's property, plant and equipment at cost has grown at a 1.2% compound annual growth rate (CAGR), from $4.97M to $5.26M.